Objectives: To evaluate the effect of a symptom management mobile application on quality of life and symptom severity in women with breast cancer undergoing chemotherapy.
Sample & Setting: This parallel randomized pilot study consisted of women with breast cancer admitted to oncology outpatient clinics between November 2019 and January 2021 in Turkey.
Methods & Variables: Participants (N = 40) were randomly assigned to the intervention (n = 20) or control group (n = 20).